Development and evaluation of actseq: a targeted next-generation sequencing panel for clinical oncology use

HIGHLIGHTS

• who: Zonggao Shi et al. from the Harper Cancer Research Institute and Department of Chemistry and Biochemistry, University of Notre have published the paper: Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use, in the Journal: PLOS ONE of November/25,/2021
• what: The funder had no role in study design data collection and analysis Purpose
• how: For somatic variant calling the authors used OncoSpan HD827 DNA sample for performance evaluation.

SUMMARY

Next generation sequencing (NGS) technologies are transforming the practice of many . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.